Portfolio company
Kezar Life Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This clinical-stage biopharmaceutical company develops small-molecule therapeutics for patients with autoimmune diseases and inflammatory conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
Kronos Bio
This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
Cabaletta Bio
This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.
Selecta Biosciences
This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.
DICE Therapeutics
This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.
Boulevard Bio
This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.
Imagene
This clinical-stage biotechnology company develops therapeutics for patients with immunological, autoimmune and inflammatory diseases to improve quality of life.
